Zhibin Xu

机构：Chinese Academy of Sciences, Shantou University, Shantou University Medical College, Shenzhen Institutes of Advanced Technology, Jiangsu Hengrui Medicine (China) · ORCID：0009-0007-5933-9737

发表论文 14 篇 · 总被引 102 次 · h-index 5

代表论文

• Comparative gastrointestinal adverse effects of GLP-1 receptor agonists and multi-target analogs in type 2 diabetes: a Bayesian network meta-analysis (2025 · Frontiers in Pharmacology · 被引 34)
• Hypothalamic CRF neurons facilitate brain reward function (2024 · Current Biology · 被引 26)
• SHR-A1811, a novel anti-HER2 antibody–drug conjugate with optimal drug-to-antibody ratio, efficient tumor killing potency, and favorable safety profiles (2025 · PLoS ONE · 被引 17)
• Menthol Flavor in E-Cigarette Vapor Modulates Social Behavior Correlated With Central and Peripheral Changes of Immunometabolic Signalings (2022 · Frontiers in Molecular Neuroscience · 被引 11)
• Interleukin 13 signaling modulates dopaminergic functions and nicotine reward in rodents (2025 · Molecular Psychiatry · 被引 5)
• MiceVAPORDot: A novel automated approach for high-throughput behavioral characterization during E-cigarette exposure in mice (2023 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 4)